InvestorsHub Logo
Followers 800
Posts 50842
Boards Moderated 2
Alias Born 12/12/2004

Re: crudeoil24 post# 358491

Wednesday, 09/28/2016 9:18:56 AM

Wednesday, September 28, 2016 9:18:56 AM

Post# of 638103
AVXL > news: Anavex Compound to be Tested in Biogen Neurological Protection Model
1 hour 39 minutes ago - DJNF
Anavex Compound to be Tested in Biogen Neurological Protection Model
NEW YORK, Sept. 28, 2016 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. ("Anavex" or the "Company") (Nasdaq:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases including Alzheimer's disease, other central nervous system (CNS) diseases, pain and various types of cancer, today announced that it has signed a material transfer agreement with Biogen (Cambridge, MA) under which Biogen will test Anavex's lead drug candidate, ANAVEX 2-73 in an oligodendrocyte precursor cell (OPC) differentiation assay. A satisfactory result from the OPC assay study may lead to an in vivo remyelination study using a chemical demyelination model.

"Battling demyelinating diseases such as multiple sclerosis requires an understanding of the processes that cause remyelination to fail. Remyelination of demyelinated axons is typically a function of oligodendrocyte precursor cells. These studies will examine the therapeutic role ANAVEX 2-73 may play in permitting remyelination in the brain," said Christopher U. Missling, PhD, President and Chief Executive Officer of Anavex.

About Biogen

Through cutting-edge science and medicine, Biogen (Nasdaq:BIIB) discovers, develops and delivers worldwide innovative therapies for people living with serious neurological, autoimmune and rare diseases. Founded in 1978, Biogen is one of the world's oldest independent biotechnology companies and patients worldwide benefit from its leading multiple sclerosis and innovative hemophilia therapies. For more information, please visit www.biogen.com. Follow us on Twitter.

DUKE BASKETBALL and NOTRE DAME FOOTBALL

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.